PANTHERNA THERAPEUTICS
Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on advanced nanoparticles for the delivery and expression of therapeutic mRNA drugs in the endothelium. Pantherna is based in Hennigsdorf (Brandenburg) close to Berlin, Germany.
PANTHERNA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
Hennigsdorf, Brandenburg, Germany
Country:
Germany
Website Url:
http://www.pantherna-therapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+49(0)3302-202 240-0
Email Addresses:
[email protected]
Total Funding:
3.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Microsoft Exchange Online Office 365 Mail
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
MC2 Therapeutics
MC2 Therapeutics is a privately held emerging pharmaceutical company.
Pentraxin Therapeutics
Pentraxin Therapeutics is a University College London spin out company founded in 2001
PTC Therapeutics Sweden AB
PTC Therapeutics Sweden AB is a Therapeutics and Pharmaceuticals company.
Current Employees Featured
Founder
Investors List
European Investment Fund
European Investment Fund investment in Seed Round - Pantherna Therapeutics
Detlev Riesner
Detlev Riesner investment in Seed Round - Pantherna Therapeutics
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Seed Round - Pantherna Therapeutics
Official Site Inspections
http://www.pantherna-therapeutics.com
- Host name: r2172.agenturserver.it
- IP address: 178.16.61.39
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Pantherna Therapeutics"
Pantherna Therapeutics - Crunchbase Company Profile & Funding
Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on …See details»
Pantherna Therapeutics - PitchBook
Pantherna Therapeutics General Information Description. Operator of a biopharmaceutical company intended to develop therapeutics for vascular …See details»
Pantherna Therapeutics GmbH - Hennigsdorf, Germany
Jan 13, 2022 Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases. Pantherna's innovative technology …See details»
Pantherna Therapeutics - HTGF
Pantherna Therapeutics is a privately-held biopharmaceutical company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on …See details»
Pantherna Therapeutics | Drug Discovery News
Sep 5, 2024 Organization profile for Pantherna Therapeutics on Drug Discovery News. Subscribe today! Research Areas. Research Areas; Neuroscience; Cancer Research; …See details»
Pantherna Therapeutics - Craft
Pantherna Therapeutics is a biopharmaceutical company engaged in the development of therapeutics for vascular diseases. The company uses a technology platform based on …See details»
Pantherna Therapeutics
Description: Pantherna Therapeutics is a privately held mRNA therapeutics company developing novel first-in-class therapies for indications with high unmet medical need. Pantherna’s …See details»
Technology - Pantherna Therapeutics
Pantherna has developed cutting-edge genetic therapeutics through its PTXmRNA® and PTXΔLNP® technologies. PTXmRNA® is a proprietary technology by Pantherna, …See details»
Pantherna Therapeutics - Funding, Financials, Valuation & Investors
Pantherna Therapeutics is a privately-held biopharmaceutical company. AI Content may contain mistakes and is not legal, financial or investment advice.See details»
TQ Therapeutics GmbH
Christin´s expertise lies in the field of commercial strategy and organization design with over 8 years of experience in strategy consulting for the pharmaceutical & life science industry, as …See details»
Pantherna Therapeutics (Pantherna Therapeutics GmbH) - Startbase
Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on …See details»
News | Astellas Pharma Inc.
Oct 4, 2022 TOKYO and Hennigsdorf, Germany, October 4, 2022 - Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Pantherna …See details»
Pantherna Therapeutics GmbH - VentureRadar
Pantherna Therapeutics is a privately-held biopharmaceutical company founded in 2014 and developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology …See details»
Pantherna Therapeutics GmbH (Pantherna Therapeutics GmbH)
Pantherna is pursuing the development of a pipeline of novel mRNA-LNP candidates that will enable the therapeutic use of mRNA in various tissues and cell types. www.pantherna …See details»
Astellas and Pantherna Enter into a New Technology Evaluation …
Oct 3, 2022 About Pantherna Pantherna Therapeutics is a privately held biopharmaceutical company developing first-in-class therapeutics for vascular diseases. Pantherna's innovative …See details»
Pantherna's LNP technology for RNA delivery beyond liver
Pantherna’s strategy for advancing its PTXΔLNP delivery systems to unlock commercial partnerships, illustratrating various therapeutic areas and target organs. Pantherna aims to …See details»
Pantherna and WACKER Intensify Collaboration in the …
Apr 5, 2024 Manufacture of the PAN004 active ingredient supplied by Pantherna Therapeutics, a biotech company, is based on a large-scale production process developed by WACKER for …See details»
Astellas and Pantherna Collaborate on Research to Generate …
Oct 5, 2022 Pantherna owns a proprietary platform of state-of-the-art, unique mRNA molecules (PTXmRNAs) for enhancing the efficiency of mRNA actions in the body. Under the new …See details»
Pantherna Therapeutics - Wacker
的技术转移工作正在紧锣密鼓地进行，我们相信Pantherna 将很好地 受益于我们在生产领域的专长。” Pantherna Therapeutics 公司首席科学家（CSO）Jörg Kaufmann 博 士说：“我们与瓦克 …See details»
Eterna Therapeutics Changes Name to Ernexa Therapeutics to …
6 hours ago Ernexa Therapeutics embarks on new strategic direction, shifting the company’s focus from delivering a cell therapy platform to prioritizing product developmentSee details»